Abstract
Epstein–Barr virus is associated with a number of human proliferative and malignant diseases. It is capable of immortalizing human primary B-lymphocytes in vitro. Studies indicate that latent membrane protein LMP1 is one of the viral proteins essential for this process. In this report, LMP1 was shown to prevent primary mouse embryonic fibroblasts from entering into replicative senescence in vitro. It further suppresses the senescence-associated induction of p16INK4a, commonly believed to be a key regulator of replicative senescence. In addition, LMP1 was shown to prevent premature senescence provoked by oncogenic ras in mouse embryonic fibroblasts, and to inhibit the oncogene ras-mediated induction of p16INK4a and p21WAF1. In parallel, LMP1 also prevents ras-induced premature senescence in rat embryonic fibroblasts REF52 and human diploid fibroblasts IMR90. Moreover, LMP1 is capable of suppressing the p16INK4a promoter in REF52 and Saos-2 cells in a promoter reporter assay. Our findings suggest that with the expression of p16INK4a and replicative senescence being suppressed, LMP1 may play a key role in Epstein–Barr virus-associated proliferative diseases, and it may further contribute to cancer development by preventing premature senescence induced by mitogenic oncogenes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D and Barrett JC . 1996 Proc Natl Acad Sci USA 93: 13742–13747
Baichwal VR and Sugden B . 1989 Oncogene 4: 67–74
Bond J, Haughton M, Blaydes J, Gire V, Wynford-Thomas D and Wyllie F . 1996 Oncogene 13: 2097–2104
Brown JP, Wei W and Sedivy JM . 1997 Science 277: 831–834
Campisi J . 1996 Cell 84: 497–500.
Campisi J . 1997 Eur J Cancer 33: 703–709
Cao L, Faha B, Dembski M, Tsai LH, Harlow E and Dyson N . 1992 Nature 355: 176–179
Cohen JI, Wang F, Mannick J and Kieff E . 1989 Proc Natl Acad Sci USA 86: 9558–9562
Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacock M and Campisi J . 1995 Proc Natl Acad Sci USA 92: 9363–9367
Draetta GF . 1994 Curr Opin Cell Biol 6: 842–846
El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B . 1993 Cell 75: 817–825
Eliopoulos AG and Young LS . 1998 Oncogene 16: 1731–1742
Epstein M, Achong B and Barr Y . 1964 Lancet 1: 702–703
Farnsworth CL and Feig LA . 1991 Mol Cell Biol 11: 4822–4829
Franza Jr BR, Maruyama K, Garrels JI and Ruley HE . 1986 Cell 44: 409–418
Gires O, Kohlhuber F, Kilger E, Baumann M, Kieser A, Kaiser C, Zeidler R, Scheffer B, Ueffing M and Hammerschmidt W . 1999 EMBO J 18: 3064–3073
Gires O, Zimber-Strobl U, Gonnella R, Ueffing M, Marschall G, Zeidler R, Pich D and Hammerschmidt W . 1997 EMBO J 16: 6131–6140
Goldstein S . 1990 Science 249: 1129–1133
Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, Petersen V and Freese UK . 1985 New Engl J Med 313: 1564–1571
Gulley ML, Nicholls JM, Schneider BG, Amin MB, Ro JY and Geradts J . 1998 Am J Pathol 152: 865–869
Hammerschmidt W and Sugden B . 1989 Nature 340: 393–397
Hammerschmidt W, Sugden B and Baichwal VR . 1989 J Virol 63: 2469–2475
Hara E, Smith R, Parry D, Tahara H, Stone S and Peters G . 1996 Mol Cell Biol 16: 859–867
Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A and Donehower LA . 1993 Oncogene 8: 2457–2467
Hayflick L and Moorhead PS . 1961 Exp Cell Res 25: 585–621
Henle G, Henle W, Clifford P, Diehl V, Kafuko GW, Kirya BG, Klein G, Morrow RH, Munube GM, Pike P, Tukei PM and Ziegler JL . 1969 J Natl Cancer Inst 43: 1147–1157
Huen DS, Henderson SA, Croom-Carter D and Rowe M . 1995 Oncogene 10: 549–560
Izumi KM, Kaye KM and Kieff ED . 1997 Proc Natl Acad Sci USA 94: 1447–1452
Izumi KM and Kieff ED . 1997 Proc Natl Acad Sci USA 94: 12592–12597
Jarrett RF, Gallagher A, Jones DB, Alexander FE, Krajewski AS, Kelsey A, Adams J, Angus B, Gledhill S, Wright DH, Cartwright RA and Onions DE . 1991 J Clin Pathol 44: 844–848
Kaye KM, Izumi KM and Kieff E . 1993 Proc Natl Acad Sci USA 90: 9150–9154
Kaye KM, Izumi KM and Kieff E . 1995 J Virol 69: 675–683
Kaye KM, Izumi KM, Li H, Johannsen E, Davidson D, Longnecker R and Kieff E . 1999 J Virol 73: 10525–10530
Kieff E . 1996 Epstein-Barr virus and its replication In Fields BN, Knipe DM and Howley PM . Fields Virology 3rd edn Lippincott-Raven Publishers Philadelphia, PA pp 2343–2396
Kieser A, Kilger E, Gires O, Ueffing M, Kolch W and Hammerschmidt W . 1997 EMBO J 16: 6478–6485
Kilger E, Kieser A, Baumann M and Hammerschmidt W . 1998 EMBO J 17: 1700–1709
Kulju KS and Lehman JM . 1995 Exp Cell Res 217: 336–345
Levine AJ . 1997 Cell 88: 323–331
Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M and Lowe SW . 1998 Genes Dev 12: 3008–3019
Leone G, Mc DeGregori J, Sears R, Jakoi L and Nevins JR . 1997 Nature 387: 422–426
Low KG, Dorner LF, Fernando DB, Grossman J, Jeang KT and Comb MJ . 1997 J Virol 71: 1956–1962
Magrath I . 1990 Adv Cancer Res 55: 133–270
Mannick JB, Cohen JI, Birkenbach M, Marchini A and Kieff E . 1991 J Virol 65: 6826–6837
McConnell BB, Starborg M, Brookes S and Peters G . 1998 Curr Biol 8: 351–354
McCormick F and Wittinghofer A . 1996 Curr Opin Biotechnol 7: 449–456
Metz T, Harris AW and Adams JM . 1995 Cell 82: 29–36
Mitchell T and Sugden B . 1995 J Virol 69: 2968–2976
Moorthy RK and Thorley-Lawson DA . 1993 J Virol 67: 1638–1646
Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C and Kieff E . 1995 Cell 80: 389–399
Pantoja C and Serrano M . 1999 Oncogene 18: 4974–4982
Pathmanathan R, Prasad U, Sadler R, Flynn K and Raab-Traub N . 1995 New Engl J Med 333: 693–698
Purtilo DT, Cassel CK, Yang JP and Harper R . 1975 Lancet 1: 935–940
Raab-Traub N and Flynn K . 1986 Cell 47: 883–889
Rickinson AB and Kieff E . 1996 Fields Virology Lippincott-Raven Publishers, Philadelphia, PA pp 2397–2446
Roussel MF . 1999 Oncogene 18: 5311–5317
Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D and DePinho RA . 1996 Cell 85: 27–37
Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW . 1997 Cell 88: 593–602
Spruck CH, Tsai YC, Huang DP, Yang AS, Rideout WM, Gonzalez-Zulueta M, Choi P, Lo KW, Yu MC and Jones PA . 1992 Cancer Res 52: 4787–4790
Stein GH and Dulic V . 1995 Bioessays 17: 537–543
Stein GH, Drullinger LF, Soulard A and Dulic V . 1999 Mol Cell Biol 19: 2109–2117
Sun Y, Hegamyer G, Cheng YJ, Hildesheim A, Chen JY, Chen IH, Cao Y, Yao KT and Colburn NH . 1992 Proc Natl Acad Sci USA 89: 6516–6520
Sun Y, Hildesheim A, Lanier AE, Cao Y, Yao KT, Raab-Traub N and Yang CS . 1995 Oncogene 10: 785–788
Suzuki T, Kitao S, Matsushime H and Yoshida M . 1996 EMBO J 15: 1607–1614
Tomkinson B, Robertson E and Kieff E . 1993 J Virol 67: 2014–2025
Uhrbom L, Nister M and Westermark B . 1997 Oncogene 15: 505–514
Wang D, Liebowitz D and Kieff E . 1985 Cell 43: 831–840
Yang XH, Sham JST, Ng MH, Tsao SW, Zhang DK, Lowe SW and Cao L . 2000 J Virol 74: 883–891
Zhu J, Woods D, McMahon M and Bishop JM . 1998 Genes Dev 12: 2997–3007
Zindy F, Quelle DE, Roussel MF and Sherr CJ . 1997 Oncogene 15: 203–211
Zur Hausen H and Schulte-Holthausen H . 1970 Nature 227: 245–248
Acknowledgements
We are very grateful for Drs FA Grasser for the LMP1 plasmid, D Thorley-Lawson for S12 antibody against LMP1, SW Lowe for the pLNSX-H-rasV12 plasmid, JR Nevins for the adenovirus with H-ras61L and REF52 cell line, G Peters for the p16 promoter reporter plasmid, B Vogelstein for the WAF1 promoter reporter plasmid, and D Goeddel for the ELAM-luciferase reporter plasmid. We also thank Ms CP Chan for assistance in data preparation, Drs J Zhong and DY Jin for comments on the manuscript. This work was supported by grants from RGC of Hong Kong and Croucher Foundation to L Cao.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yang, X., He, Z., Xin, B. et al. LMP1 of Epstein–Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression. Oncogene 19, 2002–2013 (2000). https://doi.org/10.1038/sj.onc.1203515
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203515
Keywords
This article is cited by
-
Challenging Tumor Heterogeneity with HER2, p16 and Somatostatin Receptor 2 Expression in a Case of EBV-Associated Lymphoepithelial Carcinoma of the Salivary Gland
Head and Neck Pathology (2023)
-
Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Nature Reviews Molecular Cell Biology (2006)
-
Epstein–Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity
Oncogene (2005)
-
RECK is a target of Epstein–Barr virus latent membrane protein 1
Oncogene (2003)
-
The Molecular Basis for the Generation of Hodgkin and Reed-Sternberg Cells in Hodgkin’s Lymphoma
International Journal of Hematology (2003)